Posts by author
Janet Fricker
Antibody-drug conjugate proves effective against active brain metastases
The antibody drug conjugate trastuzumab deruxtecan (T-DXd) showed substantial intracranial activity in patients with HER2-positive breast cancer whose disease had metastasised to the brain. The DESTINY-Breast12 study, presented at the Congress of the European Society for Medical Oncology (ESMO), held…
Safely pausing or stopping treatment: could this be the future for solid tumours?
The success of treatment cessation in chronic myeloid leukaemia (CML), outlined in an earlier Cancerworld feature, is opening the way for treatment breaks – or cessation with monitoring – to be considered in advanced solid tumours, including breast, kidney, colorectal,…
Early menopause raises own risk of breast cancer and family members’ risk of breast, colon and prostate cancers
Women who experience primary ovarian insufficiency (menopause before the age of 40) are more than twice as likely to experience breast cancer as other women of similar ages. The study, published in the Journal of Clinical Endocrinology and Metabolism, 12…
Raised suicide risk highlights need to support patient’s spouse
The spouses of patients diagnosed with cancer were 28% more likely to attempt suicide and 47% more likely to succeed at their attempt than spouses of people not diagnosed. The Danish cohort study, published in Jama Oncology, August 15, found…
Aspirin prevents colorectal cancer best in those with least healthy lifestyles
Regular aspirin may help lower risk of colorectal cancer most effectively in people who have greater lifestyle-related risk factors for the disease. The study, published in JAMA Oncology on 1 August, found that, to prevent one case of colorectal cancer…
Endometriosis: impact on ovarian cancer varies by subtype
Women with endometriosis have a fourfold higher risk of any type of ovarian cancer and those with severe endometriosis a 10 fold higher risk compared to women who do not have the condition. The study, which involved a cohort of…
Disadvantaged neighbourhoods may contribute to racial disparities in risk of aggressive prostate cancer
Men with prostate cancer living in disadvantaged neighbourhoods show significantly higher activity of stress-related genes than those living in other neighbourhoods. The observational study, published in JAMA Network Open, 12 July, found that neighbourhood disadvantage was positively associated with the…
Exercise boosts anti-tumour immune cells in people with breast cancer
Just 30 minutes of exercise increases the proportion of tumour-killing immune cells in the blood of people with breast cancer. The Finnish study, published in Frontiers in Immunology, 24 June, found that the proportion of CD8+ T cells and natural…
Treatment-free remission: How today’s CML patients can aspire to a drug-free life
Around the start of the millennium, the therapeutic landscape for chronic myeloid leukaemia (CML), a rare type of blood cancer affecting the bone marrow and white blood cells, was transformed by the arrival of a revolutionary cancer drug. This was…
Liver biopsies can predict when and where pancreatic cancer will metastasise and may guide treatment of early-stage disease
Liver biopsies undertaken at the time of surgery for pancreatic cancer can be used to identify cellular and molecular markers that predict whether early pancreatic cancer will later metastasise to the liver. The study, published in Nature Medicine, June 28,…